Talis Biomedical Corp (OQ:TLIS)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for TLIS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series D-2 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -856,370  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series C-1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -10,214,159  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series C-1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -963,490  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series C-1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -4,975  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 6,427,576  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 536,438  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 7,286,794  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 536,414  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 1,941  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 6,654,603  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for TLIS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 24th, 2021
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series D-2 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -856,370  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series C-1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -10,214,159  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series C-1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -963,490  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series C-1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 -4,975  
Feb 19/21 Nov 2/20 Baker Bros. Advisors Lp Indirect Ownership Series F-2 Convertible Preferred Stock A - Grant, award or other under Rule 16b-3(d) 9,191,433 $8.55
Feb 19/21 Nov 2/20 Baker Bros. Advisors Lp Indirect Ownership Series F-2 Convertible Preferred Stock A - Grant, award or other under Rule 16b-3(d) 767,106 $8.55
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 6,427,576  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 536,438  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 7,286,794  
Feb 19/21 Feb 17/21 Baker Bros. Advisors Lp Indirect Ownership Series 1 Convertible Preferred Stock M - Exercise or conversion exempt under rule 16b-3 536,414  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $TLIS

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
Crispr Therapeutics AG (OQ:CRSP)
Revolution Medicines (OQ:RVMD)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.